Training activity information
Details
Respond to clinical queries/ significant results related to the diagnosis and management of infection in patients with solid organ malignancies and transplants.
To include selection and interpretation of relevant tests and drafting of advice.
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What specific knowledge regarding immunosuppression, common infections post-transplant, and interaction with malignancy treatment do you need to review?
- What specific insights into the complexities of infection in patients with solid organ malignancies and transplant recipients are you aiming for?4 What is your existing knowledge about the different phases of post-transplant infection risk?
- Have you discussed potential clinical scenarios and queries related to this patient group with your training officer? What challenges might you encounter in balancing the management of infection with the patient’s underlying condition and immunosuppression? How might you handle this? How do you feel as you prepare for this activity?
In action
- What are your immediate actions upon receiving the clinical query or significant result?
- What is your thought process as you begin to formulate a response?
- What key decisions are you making about test selection, result interpretation, and the infection management advice you are drafting?
- Which aspects of this task are drawing on your established microbiological knowledge, and which require more specific attention to the nuances of solid organ malignancies and transplantation?
- How effective do you perceive your current actions to be in reaching an appropriate diagnosis and management plan?
- What specific difficulties or complexities are arising due to the patient’s solid organ malignancy or transplant status?
- What are you learning about the unique challenges of infection in this patient group as you engage with this DTA?
- How does this experience build upon your existing knowledge of microbiology, immunology, and the impact of organ transplantation?
- Are you considering alternative diagnostic approaches or management strategies based on the evolving information?
- Do you identify any points where seeking immediate advice or clarification would be beneficial?
- Are you ensuring your actions and recommendations align with your professional boundaries and current ability?
On action
- Begin by summarising the key points of the experience of responding to clinical queries/significant results for patients with solid organ malignancies and transplants.
- What skills or knowledge did you develop or improve related to the selection and interpretation of relevant tests for this immunosuppressed patient group?
- Were there any unexpected challenges or successes in drafting advice, considering the specific infection risks associated with different types of solid organ malignancies and transplants?
- What did you learn from these? In what ways did your reflection-in-action (during the activity) influence your approach to test selection and interpretation?
- How does this experience relate to the requirements for post-programme practice in providing specialist microbiology input for patients with solid organ malignancies and transplants?
- What areas for continued development have been identified in responding to clinical queries for this patient group?
- How can you apply the learning from this activity to your routine practice, especially in understanding the nuances of post-transplant infections and antimicrobial prophylaxis?
- Identify the actions / ‘next steps’ you will now take to support the assimilation of what you have learned, such as reviewing transplant infection guidelines or discussing cases with transplant physicians.
- What support or resources might you need to further develop your skills in this area, such as attending relevant conferences or seeking specialist mentorship?
Beyond action
- How has your understanding of managing infections in patients with solid organ malignancies and transplants evolved since undertaking this DTA and gaining further experience?
- How have you applied the skills and knowledge gained from this DTA regarding test selection, interpretation, and advice drafting for this patient group to other immunosuppressed or post-surgical patient scenarios?
- What connections can you draw between this DTA and other training activities or clinical experiences, such as attending relevant multidisciplinary team meetings or interpreting transplant serology, and how do they build towards your overall development as a Healthcare Scientist?
- What further development needs related to infections in solid organ malignancies/transplant patients have been identified through revisiting this experience, and what actions will you now take?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Identify appropriate investigative strategies to diagnose and manage infections associated with specialist patient groups, considering guidance and public health requirements |
| # 2 |
Outcome
Select tests to diagnose and manage infections and interpret the results in the clinical context for specialist patient groups, with consideration of laboratory quality assurance and quality control |
| # 3 |
Outcome
Develop plans and provide advice on infection management for specialist patient groups considering infection control, guidelines and public health requirements |